Seiya Yamayoshi, Etsuko Nagai, Keiko Mitamura, Masao Hagihara, Ryo Kobayashi, Satoshi Takahashi, Akimichi Shibata, Yoshifumi Uwamino, Naoki Hasegawa, Asef Iqbal, et al. Seroprevalence of severe acute respiratory syndrome coronavirus 2 N antibodies between December 2021 and march 2023 in Japan. Epidemiology and infection. 2024. 152. e24
Taketomo Maruki, Hidetoshi Nomoto, Noriko Iwamoto, Kei Yamamoto, Masami Kurokawa, Kiyoko Iwatsuki-Horimoto, Seiya Yamayoshi, Yutaka Suzuki, Yoshihiro Kawaoka, Norio Ohmagari. Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymphoma. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024
Aya Ishizaka, Michiko Koga, Taketoshi Mizutani, Seiya Yamayoshi, Kiyoko Iwatsuki-Horimoto, Eisuke Adachi, Yutaka Suzuki, Yoshihiro Kawaoka, Hiroshi Yotsuyanagi. Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV. BMC microbiology. 2024. 24. 1. 6-6